Form 8-K - Current report:
SEC Accession No. 0000318306-11-000023
Filing Date
2011-11-10
Accepted
2011-11-10 17:23:48
Documents
4
Period of Report
2011-11-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8K r8k-302.htm 8-K 30457
2 SECURITIES PURCHASE AGREEMENT r8k-303.htm EX-10.1 349855
3 FORM OF WARRANT - TWO AND ONE HALF YEAR WARRANT r8k-304.htm EX-10.2 126236
4 FORM OF WARRANT - FIVE YEAR WARRANT r8k-305.htm EX-10.3 133569
  Complete submission text file 0000318306-11-000023.txt   641438
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 111196497
SIC: 2834 Pharmaceutical Preparations